News & Updates

Liver transplantation improves vitamin A, E status in kids with chronic liver disease

08 Mar 2020

Deficiency in fat-soluble vitamins (FSV) is common among children with chronic liver disease, a recent study has found. Liver transplantation appears to improve FSV status.

Liver transplantation improves vitamin A, E status in kids with chronic liver disease

08 Mar 2020

Magnetic resonance unreliable for assessing NASH treatment response

06 Mar 2020

Magnetic resonance imaging may not be a reliable strategy for detecting changes in liver histology and may thus have limited value in assessing treatment response in patients with fatty liver, reports a new study.

Magnetic resonance unreliable for assessing NASH treatment response

06 Mar 2020

Omega-3 fatty acid infusions do not protect against complications in liver surgery

05 Mar 2020

The infusion of two single doses of Omega-3 polyunsaturated fatty acids before and after liver surgery does not appear to reduce the risk of complications, a new study has found.

Omega-3 fatty acid infusions do not protect against complications in liver surgery

05 Mar 2020

Glecaprevir-pibrentasvir combo safe, effective for HCV infections

03 Mar 2020

Eight-week treatment with glecaprevir plus pibrentasvir is effective for chronic infections of hepatitis C virus (HCV) of genotypes 1–6, without substantial safety concerns, a recent study has found.

Glecaprevir-pibrentasvir combo safe, effective for HCV infections

03 Mar 2020

CheckMate 040: Nivolumab, cabozantinib ± ipilimumab improves outcomes in aHCC

03 Mar 2020 by

The combination therapy of nivolumab (NIVO) and cabozantinib (CABO) with or without ipilimumab (IPI) demonstrates activity in advanced hepatocellular carcinoma (aHCC), according to the CheckMate 040* study presented at ASCO GI 2020.

CheckMate 040: Nivolumab, cabozantinib ± ipilimumab improves outcomes in aHCC

03 Mar 2020

HCV clearance may improve glucose metabolism

24 Feb 2020

Abnormal glycometabolism is more common among patients with hepatitis C virus (HCV) infection, and viral clearance may improve glucose control, a recent study has found.

HCV clearance may improve glucose metabolism

24 Feb 2020

Liver stiffness linked to HCC survival, recurrence after ablation

19 Feb 2020

Liver stiffness (LS) may predict the recurrence of hepatocellular carcinoma (HCC) after radiofrequency ablation (RFA), a recent study has found. Spleen stiffness (SS), on the other hand, may precede hepatic decompensation.

Liver stiffness linked to HCC survival, recurrence after ablation

19 Feb 2020

Tenofovir on par with entecavir for HCC prevention in CHB patients

17 Feb 2020

No significant difference is seen between entecavir and tenofovir disoproxil fumarate (TDF) in terms of their effectiveness for preventing hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB), according to a recent study.

Tenofovir on par with entecavir for HCC prevention in CHB patients

17 Feb 2020

High fructose intake not linked to negative metabolic effects in healthy individuals

10 Feb 2020

Prolonged ingestion of a high-dose dietary fructose does not result in relevant metabolic consequences in the presence of a stable energy intake, slightly lower body weight and potentially incomplete absorption of orally administered fructose load, according to a study.

High fructose intake not linked to negative metabolic effects in healthy individuals

10 Feb 2020

NAFLD ups risk of coronary artery calcification

08 Feb 2020

The risk of coronary artery calcification (CAC) is elevated among nonobese men with nonalcoholic fatty liver disease (NAFLD), a recent study has found.

NAFLD ups risk of coronary artery calcification

08 Feb 2020

News & Updates

Filter by Specialty:

Specialty:

Liver transplantation improves vitamin A, E status in kids with chronic liver disease

Liver transplantation improves vitamin A, E status in kids with chronic liver disease

Magnetic resonance unreliable for assessing NASH treatment response

Magnetic resonance unreliable for assessing NASH treatment response

Omega-3 fatty acid infusions do not protect against complications in liver surgery

Omega-3 fatty acid infusions do not protect against complications in liver surgery

Glecaprevir-pibrentasvir combo safe, effective for HCV infections

Glecaprevir-pibrentasvir combo safe, effective for HCV infections

CheckMate 040: Nivolumab, cabozantinib ± ipilimumab improves outcomes in aHCC

CheckMate 040: Nivolumab, cabozantinib ± ipilimumab improves outcomes in aHCC

HCV clearance may improve glucose metabolism

HCV clearance may improve glucose metabolism

Liver stiffness linked to HCC survival, recurrence after ablation

Liver stiffness linked to HCC survival, recurrence after ablation

Tenofovir on par with entecavir for HCC prevention in CHB patients

Tenofovir on par with entecavir for HCC prevention in CHB patients

High fructose intake not linked to negative metabolic effects in healthy individuals

High fructose intake not linked to negative metabolic effects in healthy individuals

NAFLD ups risk of coronary artery calcification

NAFLD ups risk of coronary artery calcification